IP Library Patent Application 13810819
Patent Application
App. No. 13/810,819

SEMICONDUCTOR MATERIALS PREPARED FROM BRIDGED BITHIAZOLE COPOLYMERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/810,819
Abstract

The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formula (1) are suitable for use in electronic devices such as organic field effect transistors.

Claims (248)

1 . A compound of formula

wherein

A 1 and A 2 are independently S or Se,

E is selected from the group consisting of

wherein

R 1 and R 2 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 1 —R 6 , —X 2 —Ar 1 , —X 2 —Ar 2 —Ar 1 , —X 2 —Ar 2 —R 7 or —X 2 —Ar 2 —Ar 3 —R 7 ,

wherein

X 1 is —O—, —[Z 1 —O] a —, —[O—Z 1 ] a —O—, —S—, —[Z 1 —S—] a —, —[S—Z 1 ] a —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 8 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 8 C(O)— or —NR 8 —,

wherein

Z 1 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,

a is an integer of from 1 to 10, and

R 8 is H, C 1-20 -alkyl, or —Z 2 —C 6-14 -aryl,

wherein

Z 2 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

R 6 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,

X 2 is —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 9 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 9 C(O)—, —NR 9 —, —Z 3 —SiR 9 2 —Z 4 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 3 and Z 4 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 9 is H, C 1-20 -alkyl, or —Z 5 —C 6-14 -aryl,

wherein

Z 5 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 1 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein R a is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 2 and Ar 3 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein R b is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 7 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 3 —Ar 4 , —X 3 —Ar 5 —Ar 4 , —X 3 —Ar 5 —R 10 , or —X 3 —Ar 5 —Ar 6 —R 10 ,

wherein

X 3 is —Z 6 —O—Z 7 —, —Z 6 —S—Z 7 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 11 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 11 C(O)—, —NR 11 —, —Z 6 —SiR 11 2 —Z 7 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 6 and Z 7 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 11 is H, C 1-20 -alkyl or —Z 8 —C 6-14 -aryl,

 wherein

 Z 8 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 4 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein R c is independently selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 5 and Ar 6 at are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein R d is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 10 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,

R 3 , R 4 and R 5 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 4 —R 12 , —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 ,

wherein

X 4 is —[Z 9 —O] b —, —[Z 9 —S—] b —, —S(O)—, —C(O)—, —C(O)O—, —C(O)NR 14 — or C(O)S—,

wherein

Z 9 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,

b is an integer of from 1 to 10, and

R 14 is H, C 1-20 -alkyl, or —Z 10 —C 6-14 -aryl,

wherein

Z 10 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

R 12 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,

X 5 is —Z 11 —O—Z 12 , —Z 11 —S—Z 12 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 15 , —C(O)S—, —Z 11 —SiR 15 2 —Z 12 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 11 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,

Z 12 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 15 is H, C 1-20 -alkyl, or —Z 13 —C 6-14 -aryl,

wherein

Z 13 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 7 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein R e is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 8 and Ar 9 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein R f is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 13 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 6 —Ar 10 , —X 6 —Ar 11 —Ar 10 , —X 6 —Ar 11 —R 16 , or —X 6 —Ar 11 —Ar 12 —R 17 ,

wherein

X 6 is —Z 14 —O—Z 15 —, —Z 14 —S—Z 15 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 18 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 18 C(O)—, —NR 18 —, —Z 14 —SiR 18 2 —Z 15 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 14 and Z 15 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 18 is H, C 1-20 -alkyl or —Z 16 —C 6-14 -aryl,

 wherein

 Z 16 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 10 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R g , wherein R g is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 11 and Ar 12 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R h , wherein R h is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 17 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,

R 19 is O or C(CN) 2 , and

R 20 and R 21 are independently R 22 or CN,

wherein R 22 has the same meaning as R 1 ,

G 1 and G 2 are independently phenylene or a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R i , wherein R i is selected from the group consisting of a halogen, a —CN, a —NO 2 , a OH, a C 1-30 -alkyl, a C 2-30 -alkenyl, a C 2-30 -alkynyl, a —Z 17 —O—C 1-30 -alkyl, a —Z 17 —S—C 1-30 -alkyl, a —Z 17 —C 3-10 -cycloalkyl, a —Z 17 —C 5-10 -cycloalkenyl, a —Z 17 —C 8-10 -cycloalkynyl, a —Z 17 —C 6-14 -aryl, a —Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue,

wherein

C 1-30 -alkyl, C 2-30 -alkenyl, C 2-30 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R j , wherein R j is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a —OH, a —NH 2 , a —NH(C 1-20 -alkyl), a —N(C 1-20 -alkyl) 2 , a —N(C 1-20 -alkyl)-C 6-14 -aryl, a —N(C 6-14 -aryl) 2 , a —S(O) m H, a —S(O) m —C 1-20 -alkyl, a —S(O) 2 OH, a —S(O) m —OC 1-20 -alkyl, a —S(O) m —OC 6-14 -aryl, a —CHO, a —C(O)—C 1-20 -alkyl, a —C(O)—C 6-14 -aryl, a —C(O)OH, a —C(O)—OC 1-20 -alkyl, a —C(O)—OC 6-14 -aryl, a —C(O)NH 2 , a —C(O)NH—C 1-20 -alkyl, a —C(O)N(C 1-20 -alkyl) 2 , a —C(O)NH—C 6-14 -aryl, a —C(O)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(O)N(C 6-14 -aryl) 2 , a —C(S)NH 2 , —C(S)NH—C 1-20 -alkyl, a —C(S)N(C 1-20 -alkyl) 2 , a —C(S)N(C 6-14 -aryl) 2 , a —C(S)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(S)NH—C 6-14 -aryl, a —S(O) m NH 2 , a —S(O) m NH(C 1-20 -alkyl), a —S(O) m N(C 1-20 -alkyl) 2 , a —S(O) m NH(C 6-14 -aryl), a —S(O) m N(C 1-20 -alkyl)-C 6-14 -aryl, a —S(O) m N(C 6-14 -aryl) 2 , a SiH 3 , a SiH(C 1-20 -alkyl) 2 , a SiH 2 (C 1-20 -alkyl) and a Si(C 1-20 -alkyl) 3 ,

wherein m is an integer of 0, 1 or 2,

wherein C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, —C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R k , wherein R k is selected from the group consisting of a C 1-20 -alkyl, a C 2-20 -alkenyl, a C 2-20 -alkynyl, a C 1-20 -alkoxy, a —S—C 1-20 -alkyl, and a C 1-20 -haloalkyl, and

Z 17 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

L is C 6-24 -arylene or a bivalent 5 to 18 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R l , wherein R l is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a OH, a *═C(C 1-30 -alkyl) 2 , a C 1-30 -alkyl, a C 2-30 -alkenyl, a C 2-30 -alkynyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 5-10 -cycloalkenyl, a —Z 18 —C 8-10 -cycloalkynyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,

wherein

C 1-30 -alkyl, C 2-30 -alkenyl, C 2-30 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN, a —NO 2 , a *═O, a —OH, a —NH 2 , a —NH(C 1-20 -alkyl), a —N(C 1-20 -alkyl) 2 , a —N(C 1-20 -alkyl)-C 6-14 -aryl, a —N(C 6-14 -aryl) 2 , a —S(O) m H, a —S(O) o —C 1-20 -alkyl, a —S(O) 2 OH, a —S(O) o —OC 1-20 -alkyl, a —S(O) o —OC 6-14 -aryl, a —CHO, a —C(O)—C 1-20 -alkyl, a —C(O)—C 6-14 -aryl, a —C(O)OH, a —C(O)—OC 1-20 -alkyl, a —C(O)—OC 6-14 -aryl, a —C(O)NH 2 , a —C(O)NH—C 1-20 -alkyl, a —C(O)N(C 1-20 -alkyl) 2 , a —C(O)NH—C 6-14 -aryl, a —C(O)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(O)N(C 6-14 -aryl) 2 , a —C(S)NH 2 , a —C(S)NH—C 1-20 -alkyl, a —C(S)N(C 1-20 -alkyl) 2 , a —C(S)N(C 6-14 -aryl) 2 , a —C(S)N(C 1-20 -alkyl)-C 6-14 -aryl, a —C(S)NH—C 6-14 -aryl, a —S(O) o NH 2 , a —S(O) o NH(C 1-20 -alkyl), a —S(O) o N(C 1-20 -alkyl) 2 , a —S(O) o NH(C 6-14 -aryl), a —S(O) o N(C 1-20 -alkyl)-C 6-14 -aryl, a —S(O) o N(C 6-14 -aryl) 2 , a SiH 3 , a SiH(C 1-20 -alkyl) 2 , a SiH 2 (C 1-20 -alkyl) and a Si(C 1-20 -alkyl) 3 ,

wherein o is an integer of 0, 1 or 2,

C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, —C 8-10 -cycloalkynyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 2-20 -alkenyl, a C 2-20 -alkynyl, a C 1-20 -alkoxy, a —S—C 1-20 -alkyl, and a C 1-20 -haloalkyl, and

Z 18 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

or

L is

wherein

R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,

wherein

X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c —, —[S—Z 19 ] c —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 27 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 27 C(O)— or —NR 27 —,

wherein

Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene,

c is an integer of from 1 to 10, and

R 27 is H, C 1-20 -alkyl, or —Z 20 —C 6-14 -aryl,

wherein

Z 20 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,

X 8 is —Z 21 —O—Z 22 , —Z 21 —S—Z 22 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 28 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 28 C(O)—, —NR 28 —, —Z 21 —SiR 28 2 —Z 22 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 21 and Z 22 are C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 28 is H, C 1-20 -alkyl, or —Z 23 —C 6-14 -aryl,

wherein

Z 23 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 14 and Ar 15 are C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 9 —Ar 16 , —X 9 —Ar 17 —Ar 16 , —X 9 —Ar 17 —R 29 , or X 9 —Ar 17 —Ar 18 —R 29 ,

wherein

X 9 is —Z 24 —O—Z 25 —, —Z 24 —S—Z 25 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 30 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 30 C(O)—, —NR 30 —, —Z 24 —SiR 30 2 —Z 25 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein

Z 24 and Z 25 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and

R 30 is H, C 1-20 -alkyl or —Z 26 —C 6-14 -aryl,

 wherein

 Z 26 is C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 16 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R q , wherein R q is selected from the group consisting of a halogen, CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 17 and Ar 18 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R r , wherein R r is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 29 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy,

q and s are independently an integer of 0, 1, 2, 3, 4 or 5,

r is an integer of 0, 1 or 2, and

n is an integer of from 1 to 10,000.

2 . The compound of claim 1 , wherein A 1 and A 2 are S.

3 . The compound of claim 1 , wherein E is selected from the group consisting of

4 . The compound of claim 1 , wherein E is

5 . The compound of claim 1 , wherein E is

6 . The compound of claim 1 , wherein R 1 and R 2 are independently H, C 1-30 -alkyl, C 1-30 -haloalkyl, —X 1 —R 6 or —X 2 —Ar 1 ,

wherein

X 1 is —[Z 1 —O] a —, —[Z 1 —S—] a —, or —[S—Z 1 ] a —S—,

wherein

Z 1 is C 1-6 -alkylene or C 1-6 -haloalkylene, and

a is an integer of from 1 to 10,

R 6 is C 1-30 -alkyl or C 1-30 -haloalkyl,

X 2 is —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, C 1-30 -alkylene or C 1-30 -haloalkylene,

wherein Z 3 and Z 4 are independently C 1-6 -alkylene or C 1-6 -haloalkylene,

and

Ar 1 is C 6-14 -aryl, optionally substituted with 1 to 5 substituents R a , wherein R a is selected from the group consisting of a halogen, a C 1-6 -alkyl, and a C 1-6 -alkoxy.

7 . The compound of claim 1 , wherein R 1 and R 2 are independently a C 1-30 -alkyl.

8 . The compound of claim 1 , wherein R 3 is —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 ,

wherein

X 5 is a covalent bond,

Ar 7 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein R e is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 8 and Ar 9 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein R f is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 13 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.

9 . The compound of claim 1 , wherein R 3 is —X 5 —Ar 8 —R 13 ,

wherein

X 5 is a covalent bond,

Ar 8 is C 6-14 -arylene, and

R 13 is C 1-20 -alkyl.

10 . The compound of claim 1 , wherein G 1 and G 2 are independently a phenylene

or, a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue selected from the group consisting of

wherein phenylene or monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue are optionally substituted with 1 to 2 substituents R i , wherein R i is selected from the group consisting of a C 1-30 -alkyl, a —Z 17 —O—C 1-30 -alkyl, a —Z 17 —S—C 1-30 -alkyl, a —Z 17 —C 3-10 -cycloalkyl, a —Z 17 —C 6-14 -aryl, a —Z 17 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 17 -monovalent 5 to 14 membered aromatic heterocyclic residue,

wherein

C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents wherein is independently selected from the group consisting of a halogen, a —CN and a *═O,

C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue are optionally substituted with 1 to 4 substituents R k , wherein R k is independently selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl,

and

Z 17 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond.

11 . The compound of claim 1 , wherein G 1 and G 2 are independently a monocyclic bivalent 5 to 8 membered aromatic heterocyclic residue

which is substituted with 1 to 2 substituents R i , wherein R i is selected from the group consisting of a C 1-30 -alkyl and a —Z 17 —C 6-14 -aryl,

wherein

C 1-30 -alkyl and C 6-14 -aryl are optionally substituted with 1 to 4 substituents R j , wherein R j is selected from the group consisting of a halogen, a —CN and a *═O,

C 6-14 -aryl is optionally substituted with 1 to 4 substituents R k , wherein R k is selected from the group consisting of a C 1-20 -alkyl and a C 1-20 -alkoxy, and

Z 17 is a covalent bond.

12 . The compound of claim 1 , wherein R i is C 1-30 -alkyl.

13 . The compound of claim 1 , wherein

L is a bivalent 5 to 18 membered aromatic heterocyclic residue optionally substituted with 1 to 4 substituents R l , wherein R l is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,

wherein

C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,

C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl,

and

Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,

or

L is

wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,

wherein

X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S] c — or —[S—Z 19 ] c —S—,

wherein

Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, and

c is an integer of from 1 to 10,

R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,

X 8 is Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein Z 21 and Z 22 re independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.

14 . The compound of claim 1 , wherein

L is a bivalent 5 to 18 membered aromatic heterocyclic residue selected from the group consisting of

wherein the bivalent 5 to 18 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents

wherein R l is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue,

wherein

C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,

C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl, and

Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,

and

R t is hydrogen or C 1-30 -alkyl,

or

L is

wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,

wherein

X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c — or —[S—Z 19 ] c —S—,

wherein

Z 19 is C 1-6 -alkylene, C 1-6 -alkenylene or C 1-6 -haloalkylene, and

c is an integer of from 1 to 10,

R 25 is C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl,

X 8 is —Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 1-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein Z 21 and Z 22 are independently C 1-6 -alkylene, C 1-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.

15 . The compound of claim 1 , wherein

L is

wherein R 1 is selected from the group consisting of a C 1-30 -alkyl, a —Z 18 —O—C 1-30 -alkyl, a —Z 18 —S—C 1-30 -alkyl, a —Z 18 —C 3-10 -cycloalkyl, a —Z 18 —C 6-14 -aryl, a —Z 18 -monovalent 3 to 12 membered aliphatic heterocyclic residue and a —Z 18 -monovalent 5 to 14 membered aromatic heterocyclic residue.

wherein

C 1-30 -alkyl, C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,

C 3-10 -cycloalkyl, C 6-14 -aryl, monovalent 3 to 12 membered aliphatic heterocyclic residue and monovalent 5 to 14 membered aromatic heterocyclic residue is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl, a C 1-20 -alkoxy, and a C 1-20 -haloalkyl, and

Z 18 is C 1-6 -alkylene, C 1-6 -haloalkylene or a covalent bond,

or

L is

wherein R 23 and R 24 are independently H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 1-30 -haloalkyl, —X 7 —R 25 , —X 8 —Ar 13 , —X 8 —Ar 14 —Ar 13 , —X 8 —Ar 14 —R 26 or —X 8 —Ar 14 —Ar 15 —R 26 ,

wherein

X 7 is —O—, —[Z 19 —O] c —, —[O—Z 19 ] c —O—, —S—, —[Z 19 —S—] c — or —[S—Z 19 ] c —S—,

wherein

Z 19 is C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, and

c is an integer of from 1 to 10,

R 25 is C 3-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl.

X 8 is Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene, C 1-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond,

wherein Z 21 and Z 22 are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond,

Ar 13 is C 6-14 -aryl or monovalent 5 to 14 membered aromatic hetrocyclic residue, each optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl,

Ar 14 and Ar 15 are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R p , wherein R p is selected from the group consisting of a halogen, a CN, a C 1-6 -alkyl, a C 1-6 -alkoxy and a C 1-6 -haloalkyl, and

R 26 is C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy.

16 . The compound of claim 1 , wherein

R l is selected from the group consisting of a C 1-30 -alkyl and a —Z 18 —C 6-14 -aryl,

wherein

C 1-30 -alkyl and C 6-14 -aryl are optionally substituted with 1 to 4 substituents R m , wherein R m is selected from the group consisting of a halogen, a —CN and a *═O,

C 6-14 -aryl is optionally substituted with 1 to 4 substituents R n , wherein R n is selected from the group consisting of a C 1-20 -alkyl and a C 1-20 -alkoxy, and

Z 18 is a covalent bond,

and

R 23 and R 24 are independently H, C 1-30 -alkyl, C 1-30 -haloalkyl, —X 7 —R 25 or —X 8 —Ar 13 ,

wherein

X 7 is —[Z 19 —O] c —, —[Z 19 —S—] c —, or —[S—Z 19 ] c —S—,

wherein

Z 19 is C 1-6 -alkylene or C 1-6 -haloalkylene, and

c is an integer of from 1 to 10,

R 25 is C 1-30 -alkyl or C 1-30 -haloalkyl,

X 8 is —Z 21 —O—Z 22 —, —Z 21 —S—Z 22 —, C 1-30 -alkylene or C 1-30 -haloalkylene,

wherein Z 21 and Z 22 are independently C 1-6 -alkylene or C 1-6 -haloalkylene,

and

Ar 13 is C 6-14 -aryl, optionally substituted with 1 to 5 substituents R o , wherein R o is selected from the group consisting of a halogen C 1-6 -alkyl and a C 1-6 -alkoxy.

17 . The compound of claim 1 , wherein R l is C 1-30 -alkyl,

and

R 23 and R 24 are independently H, C 1-30 -alkyl or C 1-30 -haloalkyl.

18 . The compound of claim 1 , wherein q, r and s are an integer of 0 or 1, and q, r and s are not all 0 at the same time.

19 . The compound of claim 1 , wherein n is an integer of from 1 to 5000.

20 . An electronic device comprising the compound of claim 1 .

21 . The electronic device of claim 20 , wherein the electronic device is an organic field effect transistor.

22 . An organic semiconducting material comprising the compound of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2017
From: POLYERA CORPORATION
To: FLEXTERRA, INC.
Reel/Frame 041468/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2013
From: MISHRA, ASHOK KUMAR; VAIDYANATHAN, SUBRAMANIAN; NOGUCHI, HIROYOSHI; DOETZ, FLORIAN; ZHU, BO; BASUKI, JOHAN SEBASTIAN
To: BASF SE; POLYERA CORPORATION
Reel/Frame 029667/0037 →